Friday, July 10, 2026

Drug profile · INN

human coagulation factor ix

human coagulation factor ix (NONAFACT) is a coagulation factor ix exogenous protein.

EMA: withdrawn Blood and blood forming organs (B02) B02BD04
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — human coagulation factor ix
Class
Blood and blood forming organs (B02)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

human coagulation factor ix (NONAFACT) is a coagulation factor ix exogenous protein.

Key facts

INN human coagulation factor ix
Brand NONAFACT
Mechanism Coagulation factor IX exogenous protein
Target Coagulation factor IX
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD04

Mechanism of action

Coagulation factor IX exogenous protein

Primary target: Coagulation factor IX

Approval history

Authority Status Date
EMA withdrawn

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. clopidogrel Blood and blood forming organs (B01)
  6. dabigatran etexilate Blood and blood forming organs (B01)

Frequently asked questions

What is human coagulation factor ix?

human coagulation factor ix (NONAFACT) is a coagulation factor ix exogenous protein.

What is the brand name for human coagulation factor ix?

NONAFACT is a marketed brand name for human coagulation factor ix. Check FDA Drugs@FDA for the current US label holder and prescribing information.